More than 160 clinical trials are open at Providence Cancer Institute
Providence Cancer Institute is currently conducting more than 160 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
A groundbreaking immunoradiotherapy study for newly diagnosed head and neck cancers
a new study at
Providence Cancer Institute, patients with newly diagnosed head and neck cancers will be treated with five days of radiation therapy, followed by immunotherapy and
Data from pioneering studies by Marka Crittenden, M.D., Ph.D., suggest that radiation can boost responses to immunotherapy. The hopes are that the new approach will reduce distant metastases and will improve quality of life by reducing the duration of radiation and avoiding chemotherapy.